Ketoconazole Trial for Mild Autonomous Cortisol Secretion Shows Potential to Lower Cortisol Levels
A clinical trial is underway to evaluate the effects of ketoconazole on cortisol levels in patients with mild autonomous cortisol secretion (MACS).
Therapeutic Area
Therapeutic area intelligence for Cortisol Regulation with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.